归创通桥医疗科技股份有限公司（02190）于2026年3月25日发布公告，披露当日于香港联交所场内回购普通股7.9万股，占该公司已发行股本约0.0234%。
公司本次回购每股价格介乎23.56港元至24.1港元，合计支付约1,892,410港元。回购完成后，公司已发行股本为329,146,113股，库藏股数增至7,204,631股。
公告显示，本次回购根据2025年5月30日通过的购回授权进行，授权总数为31,958,111股，截至目前累计已回购4,385,000股。公司确认所有程序符合法律及香港联交所上市规则的规定。
本公告由公司董事赵中签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.